Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,544 | -14,123 | -9,445 | -5,753 | -3,749 |
| Depreciation Amortization | 3 | 50 | 47 | 42 | 35 |
| Income taxes - deferred | -1,047 | -745 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 355 | 4,540 | 3,448 | 2,204 | 1,235 |
| Other Working Capital | -706 | 5,657 | 4,767 | 2,150 | 1,165 |
| Other Operating Activity | 349 | -268 | 104 | 667 | 940 |
| Operating Cash Flow | $-4,590 | $-4,889 | $-1,078 | $-690 | $-374 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -35 | 1,865 | 1,353 | 690 | 393 |
| Financing Cash Flow | $-35 | $1,865 | $1,353 | $690 | $393 |
| Beginning Cash Position | 5,902 | 9,625 | 329 | 329 | 329 |
| End Cash Position | 1,278 | 6,602 | 603 | 329 | 348 |
| Net Cash Flow | $-4,624 | $-3,023 | $274 | $0 | $19 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,590 | -4,889 | -1,078 | -690 | -374 |
| Free Cash Flow | -4,590 | -4,889 | -1,078 | -690 | -374 |